Overview

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Status:
Completed
Trial end date:
2015-03-20
Target enrollment:
Participant gender:
Summary
This is a Double-blind Study Evaluating Desvenlafaxine Succinate (DVS SR) Sustained Release vs Placebo in the Treatment of Children and Adolescent Outpatients with Major Depressive Disorder (MDD).
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer
Treatments:
Desvenlafaxine Succinate
Fluoxetine